We therefore investigated the potential of the exosomes to alter recipient cells, by profiling gene expression changes in NSCs resulting from GSC exosome treatment, and detected down-regulated expression of glioma-associated tumor suppressors PTEN [34] and TET3 [26]. Here, TET3 is linked to central nervous system cancer.